Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Gene Polymorphism of XRCC1 Arg399Gln and Cervical Carcinoma Susceptibility in Asians: A Meta-analysis Based on 1,759 Cases and 2,497 Controls

  • Liu, Yi-Ting (Department of Clinical Epidemiology, The First Affiliated Hospital of China Medical University) ;
  • Shi, Jing-Pu (Department of Clinical Epidemiology, The First Affiliated Hospital of China Medical University) ;
  • Fu, Ling-Yu (Department of Clinical Epidemiology, The First Affiliated Hospital of China Medical University) ;
  • Zhou, Bo (Department of Clinical Epidemiology, The First Affiliated Hospital of China Medical University) ;
  • Wang, Hai-Long (Department of Clinical Epidemiology, The First Affiliated Hospital of China Medical University) ;
  • Wu, Xiao-Mei (Department of Clinical Epidemiology, The First Affiliated Hospital of China Medical University)
  • Published : 2013.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Many epidemiological studies in Asian populations have investigated associations between the Arg399Gln gene polymorphism of X-ray repair cross complementing gene 1 (XRCC1) and risk of cervical carcinoma, but no conclusions have been available because of controversial results. Therefore a meta-analysis was conducted for clarification. Relevant studies were identified by searching the Pubmed, Embase, the Web of Science, Cochrane Collaboration's database, Chinese National Knowledge Infrastructure (CNKI), Wanfang database and China Biological Medicinse (CBM) until September, 2012. A total of eight studies were included in the present meta-analysis, which described 1,759 cervical carcinoma cases and 2,497 controls. Odds ratios (ORs) and corresponding 95% confidence intervals (95%CIs) as effect size were calculated by fixed-effect or random-effect models. The overall results indicated that the XRCC1-399G/A polymorphism was marginally associated with cervical carcinoma in Asians: OR (95%CI): 1.16 (1.07, 1.26) in the G/A vs G/G inheritance model, 1.24 (0.87, 1.76)in A/A vs G/G inheritance model, 1.13 (1.01, 1.27) in the dominant inheritance model and 1.18 (0.94, 1.47) in the recessive inheritance model. Subgroup analyses on sample size showed no significant correlation in the small-sample size group but the large-sample size group was consistent with the outcomes of overall meta-analysis. In the subgroup analysis by regions, we only found significant association under the G/A vs G/G inheritance model in the Chinese population. For the non-Chinese populations, no correlation was detected in any genetic inheritance model. In the Asian populations, XRCC1-399G/A gene polymorphism was implied to be associated with cervical carcinoma.

Keywords

References

  1. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al (2000). Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett, 159, 79-86. https://doi.org/10.1016/S0304-3835(00)00537-1
  2. Bannett DA, Latham NK, Stretton C, Anderson CS (2004). Capture-recapture is a potentially useful method for assessing publication bias. J Clin Epidemiol, 57, 349-57. https://doi.org/10.1016/j.jclinepi.2003.09.015
  3. Barbisan G, Perez LO, Difranza L, et al (2011). XRCC1 Arg399Gln polymorphism and risk for cervical cancer development in Argentine women. Eur J Gynaec Oncol, 3, 274-9.
  4. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  5. Coppleson M, Reid BL (1986). Human papilloma virus and cervical cancer. Med J Aust, 145, 242.
  6. Duell EJ, Millikan RC, Pittman GS, et al (2011). Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev, 10, 217-22.
  7. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  8. Giuliano AR, Harris R, Sedjo RL, et al (2002). Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study. J Infect Dis, 186, 462-9. https://doi.org/10.1086/341782
  9. Goode EL, Ulrich CM, Potter JD (2002).Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 1513-30.
  10. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. https://doi.org/10.1136/bmj.327.7414.557
  11. Huang J, Ye F, Chen H, Lu W, Xie X (2007). The nonsynonymous single nucleotide polymorphisms of DNA repair gene XRCC1 and susceptibility to the development of cervical carcinoma and high-risk human papillomavirus infection. Int J Gynecol Cancer, 17, 668-75. https://doi.org/10.1111/j.1525-1438.2007.00840.x
  12. Jiang W, Wang ML, Zhang ZZ, et al (2009). The relationship between XRCC1 polymorphisms and the risk of cervical cancer in Jiangsu population. Acta Univ Med Nanjing, 29, 1-6.
  13. Kaizar EE (2005). Meta-analyses are observational studies: how lack of randomization impacts analysis. Am J Gastroenterol, 100, 1233-6. https://doi.org/10.1111/j.1572-0241.2005.50107.x
  14. Lamerdin JE, Montgomery MA, Stilwagen SA, et al (1995). Genomic sequence comparison of the human and mouse XRCC1 DNA repair gene regions. Genomics, 25, 547-54. https://doi.org/10.1016/0888-7543(95)80056-R
  15. Lee JM, Lee YC, Yang SY, et al (2001). Genetic polymorphisms of XRCC1 and risk of the esophageal cancer. Int J Cancer, 95, 240-6. https://doi.org/10.1002/1097-0215(20010720)95:4<240::AID-IJC1041>3.0.CO;2-1
  16. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA (1999). XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res, 59, 2557-61.
  17. Ma WP, Jin P, Guo Y (2011). Single nucleotide polymorphisms of the DNA repair genes XPD and XRCC1 and the susceptibility to cervical squamous cell carcinoma. Prog Obstet Gynecol, 20, 881-5.
  18. Matullo G, Guarrera S, Carturan S, et al (2001). DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer, 92, 562-7. https://doi.org/10.1002/ijc.1228
  19. Nelson HH, Kelsey KT, Mott LA, Karagas MR (2002). The XRCC1 Arg399Gln polymorphism and non-melanoma skin cancer: evidence of gene-environment interaction. Cancer Res, 62,152-5.
  20. Niwa Y, Matsuo K, Hirose K, et al (2005). Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects. Gynecol Oncol, 99, 43-9. https://doi.org/10.1016/j.ygyno.2005.05.018
  21. Roszak A, Lianeri M, Jagodzinski PP (2011). Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervical carcinoma. Int J Biol Markers, 26, 216-20.
  22. Settheetham W, Yuenyao P, Natphopsuk S, Settheetham D, Ishida T (2011). Genetic risk of DNA repair gene polymorphisms (XRCC1 and XRCC3) for high risk human papillomavirus negative cervical cancer in Northeast Thailand. Asian Pac J Cancer Prev, 12, 963-6.
  23. Shen MR, Jones IM, Mohrenweiser H (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res, 58, 604-8.
  24. Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for assessing the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25, 603-5. https://doi.org/10.1007/s10654-010-9491-z
  25. Tudek B (2007).Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med, 28, 258-75. https://doi.org/10.1016/j.mam.2007.05.003
  26. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
  27. Wu MT, Liu CL, Wu TN (2004). Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women. J Formos Med Assoc, 103, 337-43.
  28. Xiao HY, Wu WQ, Xie HY, Bao XM (2010). Relationship between the polymorphism of XRCC1-Arg399Gln and incidence risk of cervical cancer in the population of Guangdong. Hainan Med J, 21, 35-7.
  29. Zhang L, Ruan Z, Hong Q, et al (2012). Single nucleotide polymorphisms in DNA repair genes and risk of cervical cancer: A case-control study. Oncol Lett, 3, 351-62.

Cited by

  1. Association of X-ray Repair Cross Complementing Group 1 Arg399Gln Polymorphisms with the Risk of Squamous Cell Carcinoma of the Head and Neck: Evidence from an Updated Meta-Analysis vol.8, pp.10, 2013, https://doi.org/10.1371/journal.pone.0077898
  2. XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis vol.35, pp.2, 2014, https://doi.org/10.1007/s13277-013-1163-7
  3. The association between cytotoxic T lymphocyte-associated antigen-4 and cervical cancer vol.35, pp.4, 2014, https://doi.org/10.1007/s13277-013-1457-9
  4. Identification of XRCC1 Arg399Gln and XRCC3 Thr241Met Polymorphisms in a Turkish Population and Their Association with the Risk of Chronic Lymphocytic Leukemia vol.31, pp.3, 2015, https://doi.org/10.1007/s12288-014-0482-1